Injections of botulinum toxin type A, popularly known as or Botox, is a safe and well-tolerated, option to treat a migraine, a recurring severe vascular headache affecting affect about 10% US adults. Approved by the FDA in 2010, Botox injections decrease frequency, inhibit severity and prevent symptoms of a migraine in patients reducing their acute dependence on medication.
Botox injections contain neurotoxic protein produced by Clostridium botulinum, a bacterium responsible for causing food poisoning. Used in limited quantity, the product has immense medical and cosmetic value. In 2002, the FDA consented use of Botox injections as a cosmetic treatment to rejuvenate the face. In 2010, the regulator approved Botox injections for migraine treatment.